Bluewind Medical Secures CE Mark For Tibial Neurostimulator For Overactive Bladder
This article was originally published in Clinica
Medtronic-backed startup Bluewind Medical announced the CE mark of its OAB-1000 miniature wireless tibial neurostimulator to treat overactive bladder (OAB).
You may also be interested in...
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
R&D Roundup, November 2019: LimFlow Starts Pivotal Trial Of Peripheral Shunt; Conservative Coronary Treatment Matches Intervention In Trial
An overview of November’s 10 most-read Medtech Insight articles on topics related to research and development of new medical technology.
Koa Accel CEO Francis Duhay tells Medtech Insight what his company looks for when choosing medtech ideas to support and how his experience as a physician and inventor informs his investment strategy.